For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260127:nRSa6193Qa&default-theme=true
RNS Number : 6193Q Avingtrans PLC 27 January 2026
27 January 2026
Avingtrans Plc
("Avingtrans", the "Company", or the "Group")
Exercise of Options & TVR
Avingtrans plc (AIM: AVG), which designs, manufactures and supplies critical
components, modules, systems and associated services to the energy, medical
and industrial sectors, announces that on 27 January 2026, the Company was
notified of the exercise of 138,900 CSOP options over ordinary shares of 5p
each in the Company ("Ordinary Shares") by certain non-PDMR employees pursuant
to the Company's CSOP.
Issue of Equity
Application has been made for the admission to trading on AIM for the
138,900 new Ordinary Shares ("Admission"). It is expected that Admission will
become effective on 4 February 2026.
Total Voting Rights
Following the issue of the 138,900 new Ordinary Shares, the Company will have
a total of 33,269,322 Ordinary Shares in issue. The Company does not hold any
shares in Treasury.
The above figure may be used by shareholders as the denominator for the
calculations by which they will determine if they are required to notify their
interest in, or a change to their interest in, the Company under the FCA's
Disclosure Guidance and Transparency Rules.
The above information is provided by the Company in accordance with its
obligations under the FCA's Disclosure Guidance and Transparency Rules
Enquiries:
Avingtrans plc 01354 692 391
Roger McDowell, Chairman
Steve McQuillan, Chief Executive Officer
Stephen King, Chief Financial Officer
Singer Capital Markets (Nominated Adviser and Broker) 020 7496 3000
Sara Hale
Alex Bond
Carl Diebitsch
IFC Advisory (Financial PR) 020 3934 6630
Graham Herring
Tim Metcalfe
Zach Cohen
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END IOEUBSBRNAUAUAR
Copyright 2019 Regulatory News Service, all rights reserved